Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers
DELOGAST
Individual and Socio-economic Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers
2 other identifiers
interventional
258
1 country
10
Brief Summary
This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2017
Longer than P75 for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 8, 2017
CompletedFirst Posted
Study publicly available on registry
August 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2025
CompletedDecember 23, 2025
December 1, 2025
8 years
August 8, 2017
December 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Time limit of first doctor consultation
Median time between date of symptoms appearance and date of first consultation
baseline
Secondary Outcomes (6)
Time limit of system of care
baseline
cTNM Stage
baseline
clinical variables (i.e medical history, symptoms, entry into care pathway)
baseline
Socio-cognitive variables
baseline
Emotional variables
baseline
- +1 more secondary outcomes
Study Arms (1)
Questionnaire
EXPERIMENTALAuto and hetero questionnaire
Interventions
Auto and hetero questionnaires: * STAI Y B, State-Trait Anxiety Inventoriage * Brief COPE * RHHI-24, Revised Health Hardiness Inventory * IPQ-R, Illness Perception Questionnaire
Eligibility Criteria
You may qualify if:
- age ≥ 18 years
- oesophageal, oeso-gastric junction or gastric cancer non treated cancer
- patient informed of his diagnosis
- speak fluent french
You may not qualify if:
- history of cancer
- psychological history
- patient under guardianship-
- fortuitous diagnosis of cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Lillelead
- University of Lille Nord de Francecollaborator
Study Sites (10)
Centre hospitalier de Béthune
Béthune, France
Centre Hospitalier de Boulogne sur mer
Boulogne-sur-Mer, France
Centre hospitalier de Calais
Calais, France
centre Léonard de Vinci
Dechy, France
Centre d 'oncologie Dunkerquois
Dunkirk, France
CHRU, Hôpital Claude Huriez
Lille, 59037, France
Centre oscar Lambret
Lille, France
Centre hospitalier de Roubaix
Roubaix, France
Centre Hospitalier de Seclin
Seclin, France
Centre hospitalier de valenciennes
Valenciennes, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume Piessen, MD, PhD
University Hospital, Lille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2017
First Posted
August 11, 2017
Study Start
February 1, 2017
Primary Completion
February 7, 2025
Study Completion
February 7, 2025
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share